SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LUNR (lunar corp)
LUNR 11.70-2.7%9:51 AM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: crysball who wrote (7)6/6/1997 9:50:00 PM
From: crysball   of 29
 
Here are the P/E's of LUNR and its direct competitiors as of the close of market 6/697:
~LUNR 13+
~HOLX 24+
~NRLD 32+
From a value stanpoint LUNR has upside potential.

An interesting News Release today (with an NBC-TV feature) on DESIGNER ESTROGEN, which not only shows:
~Bone Growth equivalent to FOSAMAX,
~Far fewer Side Effects than Fosamax,
~Additional benefit of reducing Chloesterol.

It is approx. 1 year away from market......which will help all the Bone Metabolism houses (instrumentation & pharmaceutical like CBMI).

The Pharmaceutical company was not identified, but Ayerst is the granddaddy of Estrogen Therapy.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News